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Background: Although much is known about the management of peripheral arterial disease among adults in the
general population, the management of this disease among those with diabetes, and the effects of diabetic-induced
peripheral arterial disease on objectively-measured physical activity, is unclear. Here, we examined the association
between accelerometer-assessed physical activity and peripheral arterial disease among a national sample of U.S.
adults with diabetes.
Methods: Data from the 2003–2004 National Health and Nutrition Examination Survey were used. Physical activity was
measured using an accelerometer in 254 adults with diabetes. Peripheral arterial disease was assessed via ankle brachial
index. Negative binomial regression analysis was used to examine the association between physical activity and
peripheral arterial disease.
Results: Results were adjusted for age, gender, race-ethnicity, comorbidity index, smoking, HgbA1C, C-reactive protein,
homocysteine, glomerular filtration rate, microalbuminuria, peripheral neuropathy, physical functioning, and medication
use. After adjustments, participants with peripheral arterial disease engaged in 23% less physical activity (RR = 0.77,
95% CI: 0.62-0.96) than those without peripheral arterial disease.
Conclusions: These findings demonstrate an inverse association between accelerometer-assessed physical activity and
peripheral arterial disease in a national sample of U.S adults with diabetes.
Keywords: Accelerometry, Epidemiology, Exercise, National Health and Nutrition Examination Survey (NHANES)Introduction
Peripheral arterial disease, often assessed as the ratio of
systolic blood pressure in the upper and lower extrem-
ities, is a condition characterized by atherosclerotic occlu-
sive disease of the lower extremities [1], and is considered
a major risk factor for poor quality of life, lower-extremity
amputation and cardiovascular morbidity and mortality
[2]. Prevalence estimates of peripheral arterial disease are
substantially higher for adults with diabetes (range: 9.5%-
29%), compared to those without diabetes (4.5%) [3]. In-
deed, it has been shown that diabetes, along with smoking,
are main risk factors for developing peripheral arterial dis-
ease [4]. Although much is known about the management* Correspondence: ploprinzi@bellarmine.edu
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article, unless otherwise stated.of peripheral arterial disease among adults in the general
population, the management of this disease among those
with diabetes is less clear [1]; for example, peripheral ar-
terial disease is more subtle in its presentation in individ-
uals with diabetes compared to those without diabetes,
and the biology of peripheral arterial disease may be dif-
ferent in people with diabetes given the pervasive influ-
ence that diabetes has on the atherosclerotic milieu of the
peripheral vasculature. Consequently, strategies to prevent
and treat peripheral arterial disease among adults with
diabetes, in particular, are needed. One potential strategy
is the promotion of physical activity, as physical activity is
inversely associated with key parameters (e.g., inflamma-
tion) that influence peripheral arterial disease among the
general population [5], as well as those with diabetes [6].
Indeed, research using self-report physical activity
methodology has demonstrated an association betweenCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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these studies generally showing that those with peripheral
arterial disease engage in less self-reported physical activ-
ity than those without the disease. This association may
be bidirectional. It is conceivable that physical activity
may help to prevent and treat peripheral arterial disease
through, for example, modulation of inflammation and
endothelial function. Although some individuals with per-
ipheral arterial disease are asymptomatic, adults with this
condition may be less active as a result of disease-induced
functional limitations and pain resulting from claudication
[7,9]. Encouragingly, however, physical activity has been
shown to improve physical functioning [10] and increase
distance to onset of claudication pain [11], with the latter
likely as a result of physical activity-induced increased
blood flow to the periphery and enhanced economy of
movement.
Although an association between physical activity and
peripheral arterial disease has been established, short-
comings among this area of inquiry include the exclusive
utilization of self-report physical activity methodology.
This is particularly problematic as self-reported physical
activity is prone to considerable measurement error,
likely as a result of biases associated with recall, social
desirability, item-interpretation, and questionnaires not
always being age and culturally tailored [12]. Further, in
the general population, validation studies examining the
association between self-report physical activity and
some gold-standard (e.g., accelerometry) typically show a
poor correlation in the range of 0.3-0.5 [13]. We are un-
aware of any study specifically examining the agreement
between self-reported and objectively-measured physical
activity among those with peripheral arterial disease.
However, research among adults with other chronic dis-
eases that influence peripheral arterial disease, such as
obesity [14-16], demonstrates poor agreement between
self-reported and objectively-measured physical activity
[17]. This increased measurement error associated with
self-report physical activity methodology creates serious
challenges in delineating physical activity-disease associ-
ations and use of self-report methodology may provide
inaccurate estimates of physical activity among those
with chronic disease. Given the poor agreement between
self-reported and objectively-measured physical activity
among those with chronic disease, studies focusing on
those with chronic disease (including peripheral arterial
disease) are encouraged to use an objective measure of
physical activity.
Another area in this line of inquiry needing further at-
tention is the population in which the association be-
tween physical activity and peripheral arterial disease
has been examined. Despite the greater prevalence of
peripheral arterial disease among adults with diabetes,
coupled with diabetes-induced exacerbations of thiscondition [1], we are aware of no studies examining the
association between objectively-measured physical activ-
ity and peripheral arterial disease among diabetics. Simi-
lar to those without diabetes, it is expected that diabetics
with peripheral arterial disease would engage in less
objectively-measured physical activity than their diabetic
counterparts; however, we are aware of no available
study to support or refute this assertion. Thus, previous
studies on this topic may have limited generalizability to
populations (e.g., diabetics) at greatest risk for develop-
ing this disease.
To address these major gaps in the literature, the pur-
pose of this study was to examine the association between
accelerometer-assessed physical activity and peripheral ar-
terial disease among a nationally representative sample of
adults with evidence of diabetes. Accelerometry over-
comes limitations of self-report methodology by providing
an objective measure of the frequency, intensity, and dur-
ation of physical activity.
Method
Study design
Data from the 2003–2004 National Health and Nutrition
Examination Survey (NHANES) were used. NHANES is
an ongoing survey conducted by the National Center for
Health Statistics. NHANES evaluates a representative
sample of non-institutionalized U.S. civilians, selected by
a complex, multistage probability design. Briefly, partici-
pants are interviewed in their home and then subse-
quently examined in a mobile examination center.
NHANES data is publically available data, with the au-
thors using NHANES data for secondary analyses. All
procedures for data collection were approved by the Na-
tional Center for Health Statistics ethics review board,
and all participants provided written informed consent
prior to data collection.
Selection of participants
Participants of the 2003–2004 NHANES who were
chosen to be included in this study were considered to
have evidence of diabetes because they self-reported a
previous diagnosis of the disease (excluding gestational
diabetes mellitus), were taking insulin or other diabetic
medications to lower blood glucose, had a glycohemo-
globin (HgbA1C) of 6.5% or greater, or had a one-time
fasting glucose level of 126 mg/dL or higher.
In the 2003–2004 NHANES cycles, 375 participants
had diabetes and ankle brachial index (ABI) data, which
was used to determine peripheral arterial disease status.
Among these, 254 had complete data on the study variables
and constituted the analytic sample. Analyzed partici-
pants with evidence of diabetes had a lower body mass
index than those with evidence with diabetes that were
excluded due to missing accelerometer or covariate data
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variables (p > 0.05 for all).
Determination of peripheral arterial disease
Peripheral arterial disease was assessed by examination
of the ABI. Detailed procedures of the ABI examination
can be found elsewhere [18]. Briefly, participants 40 and
older were initially eligible for the ABI examination. Par-
ticipants were excluded if they had a bilateral amputation
or weighed more than 400 pounds (due to equipment lim-
itations). While participants rested in supine position, two
systolic blood pressure measurements were made in the
right arm (brachial artery) and both ankles (posterior tibial
arteries). The right ABI was calculated by dividing the
highest systolic blood pressure in the right ankle by the
highest blood pressure in the arm; similarly, the left ABI
was calculated by dividing the highest systolic blood pres-
sure in the left ankle by the highest blood pressure in the
arm [1]. The lower of the ABI readings were used in the
present analysis [19]. ABI as an indicator of peripheral
arterial disease has been validated against gold-standard
angiographically that has a sensitivity and specificity, re-
spectively, of 95% and nearly 100% [20].
There appears to be a U-shaped relationship between
ABI and cardiovascular disease morbidity and mortality
[21]. For adults with diabetes, an ABI < 1 results in an
elevated risk for cardiovascular morbidity and mortality
(i.e., greater arterial occlusion); between 1 and 1.4 is
considered normal, suggesting no evidence of peripheral
arterial disease; and above 1.4 (suggesting poorly com-
pressible vessels) is an independent risk factor for car-
diovascular disease morbidity and mortality [21,22].
Only 3 participants had an ABI > 1.4; therefore, the pri-
mary analyses combined these 3 participants with the
group that had an ABI < 1. As a result, for the primary
analyses, participants were classified into two groups:
normal ABI (1–1.4) and abnormal ABI (<1 or > 1.4) [9].
Assessment of physical activity
2003–2004 NHANES participants were asked to wear an
ActiGraph 7164 accelerometer during all activities, ex-
cept water-based activities and while sleeping. Estimates
for time spent in moderate-to-vigorous physical activity
(MVPA) were summarized in 1-minute time intervals.
Minutes with activity counts per minute ≥ 2020 were
classified as MVPA [23]. Only those participants with at
least 4 days of 10 or more hours/day of accelerometer
wear time were included in the analyses in order to en-
sure that data adequately captured habitual physical ac-
tivity patterns [23]. To monitor the amount of time the
device was worn, nonwear was defined by a period of a
minimum of 60 consecutive minutes of zero activity
counts, with the allowance of 1–2 minutes of activity
counts between 0 and 100 [23].Measurement of covariates
Various covariates were included based on previous re-
search demonstrating a link between these variables and
physical activity/ABI. These covariates included age,
gender, race-ethnicity, body mass index (BMI), comor-
bidity index, smoking (cotinine), HgbA1C, C-reactive
protein, homocysteine, glomerular filtration rate (GFR),
microalbuminuria, peripheral neuropathy, physical func-
tioning, and medication use.
Information about age, gender, and race-ethnicity were
obtained from a questionnaire. BMI was calculated from
measured weight and height (weight in kilograms di-
vided by the square of height in meters). A comorbidity
index variable was created to classify number of comor-
bidities each participant had [24]. Participants were classi-
fied as having 0 or 1+ comorbidities based on self-report
of the following chronic diseases/events: arthritis, hyper-
tension, coronary heart disease, heart attack, congestive
heart failure, stroke, cancer, emphysema, asthma, and
chronic bronchitis. Blood samples were taken in the mo-
bile examination center to assess for a variety of biological
markers. High sensitivity C-reactive protein concentration
was quantified using latex-enhanced nephelometry. Serum
cotinine was measured as a marker of active smoking
status or environmental exposure to tobacco (i.e., pas-
sive smoking). Serum cotinine was measured by an iso-
tope dilution-high performance liquid chromatography/
atmospheric pressure chemical ionization tandem mass
spectrometry. HgbA1C was measured using the Primus
instrument, which is a fully automated glycohemoglobin
analyzer using high performance liquid chromatog-
raphy. Homocysteine, a marker of endothelial function,
was measured using the fluorescence polarization im-
munoassay. Glomerular filtration rate (GFR), an assess-
ment of kidney function, was assessed from the Chronic
Kidney Disease Epidemiology equation based on speci-
fied race, sex, and serum creatinine level [25]. Microal-
buminuria was calculated as urinary albumin concentration
(mg/dL) divided by urinary creatinine concentration (g/L),
with the following gender-specific cut-points used to
denote microalbuminuria: ≥ 21 mg/g for males and ≥
24 mg/g for females [26].
Similar to other studies [3], participants were defined
as having peripheral neuropathy if the examination (using
a standard monofilament [5.07 Semmes-Weinstein nylon
monofilament]) determined at least 1 insensate area in ei-
ther foot, which is predictive of ulcers and amputations
and has demonstrated high sensitivity and specificity [27].
Participants were considered to have a functional disability
if they reported special assistance for walking (e.g., cane),
had limitations that prevented them from working, or
reported having any difficulty in the five functional dis-
ability categories reported elsewhere [28]. Lastly, a bin-
ary variable was created with participants classified as
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All statistical analyses were performed using Stata (ver-
sion 12.0, College Station, TX) and accounted for the
complex survey design by using appropriate sampling
weights, primary sampling units, and clustering vari-
ables. In an effort to maintain nationally representative
estimates, the sample weights for those with 4 or more
days of valid accelerometry data were ratio-adjusted to
maintain the age, sex, and race-ethnicity distribution of
the full sample.
Means and standard errors were calculated for con-
tinuous variables and proportions were calculated for
categorical variables. To examine the association be-
tween accelerometer-assessed MVPA and ABI, negative
binomial regression models was employed, as the out-
come variable (MVPA time) was expressed in integral
minutes and was positively skewed. Rate ratios (RR)
from the negative binomial regression reflect the rate of
events for each variable in the model while holding the
other variables in the model constant [29].
Two negative binomial regression models were com-
puted. The first model was a minimally adjusted model in-
cluding the following covariates: age, BMI, race-ethnicity,
gender, and comorbidity index. Following this, a fully ad-
justed model was computed, including the following co-
variates that have previously been shown to correlate with
physical activity and/or peripheral arterial disease: age,
BMI, race-ethnicity, gender, comorbidity index, cotinine,
HgbA1C, C-reactive protein, homocysteine, glomerular
filtration rate, microalbuminuria, peripheral neuropathy,
physical functioning, and medication use.
With regard to the fully adjusted model, there was no
evidence of multicollinearity. Evidence of multicollinearity
is likely to exist if there is correlation > 0.8 between two
covariates; if the mean variance inflation factor is > 6 or if
the highest individual variance inflation factor is > 10; or if
the tolerance statistic is < 0.1. For the fully adjusted model,
the highest correlation between two covariates was 0.55;
the mean variance inflation factor was 1.3; the highest in-
dividual variance inflation factor was 1.9; and all individual
tolerance statistics were > 0.5. Statistical significance was
established as an alpha value < 0.05.0
0 1
Figure 1 Box-and-whisker plot showing average moderate-
to-vigorous physical activity (MVPA) estimates/day (shown
on ordinate) across arterial brachial index groups (shown on
abscissa; 1 = abnormal arterial brachial index; 0 = normal arterial
brachial index).Results
Participants with normal ABI engaged in 14.3 (SE = 1.3)
min/day of MVPA, whereas participants with abnormal
ABI engaged in 11.5 (SE = 2.9) min/day of MVPA. The
distribution of physical activity across ABI status is
shown in Figure 1.Table 1 reports summary statistics for the study vari-
ables among those with normal and abnormal ABI. Par-
ticipants with abnormal ABI, compared to those with
normal ABI, had higher levels of homocysteine and were
more likely to have at least one comorbidity.
Table 2 shows the results of the negative binomial re-
gression, specifically reporting the independent effects of
ABI on MVPA. Both the minimally adjusted and fully
adjusted models were significant. In the fully adjusted
model, participants with abnormal ABI engaged in 23%
less MVPA time (RR = 0.77, 95% CI: 0.62-0.96) than
those with a normal ABI. Additionally, and although not
shown in tabular format, our findings also demonstrate
an association between C-reactive protein and ABI. After
all adjustments noted in Table 2, there was an inverse
association between ABI and log-transformed C-reactive
protein (coefficient = −1.68; 95% CI: −2.55 to −0.81; p =
0.001).
Given that ABI values > 1.4 are considered an inde-
pendent risk factor for cardiovascular morbidity and
mortality, and although acknowledging the limited sam-
ple size, secondary analyses were computed that sepa-
rated these individuals from those with a low ABI (i.e., <
1). Compared to those with normal (14 min/day) and
low (11 min/day) ABI values, the 3 participants with a
high ABI (i.e., > 1.4) engaged in the fewest minutes of
MVPA (4.8 min/day). However, when these 3 partici-
pants were excluded from the fully adjusted negative bi-
nomial regression model, the results were unchanged
(data not shown).
Lastly, additional analyses were computed to see if
duration of diabetes influenced the relationship between
MVPA and ABI. Only participants who self-reported
having diabetes (n = 188) were asked how long they have
Table 1 Weighted characteristics of analyzed participants among those with normal and abnormal ankle brachial
index, NHANES 2003-2004
Mean/proportion (95% CI)
Variable Normal ABI (1–1.4) (n = 76) Abnormal ABI (<1 or >1.4) (n = 178) P
Age (yrs) 60.2 (58.5-61.9) 60.7 (57.2-64.1) 0.74
% Male 57.8 (48.9-66.6) 46.2 (28.8-63.6) 0.22
Body mass index (kg/m2) 30.3 (29.4-31.2) 30.6 (27.1-34.1) 0.85
Race-Ethnicity 0.73
% Non-hispanic white 69.1 (56.0-82.1) 70.6 (57.3-83.9)
% Other 30.8 (17.8-43.9) 29.3 (16.0-42.6)
Cotinine (ng/mL) 43.4 (19.2-67.7) 68.7 (20.4-117.0) 0.29
HgbA1C (%) 7.1 (6.8-7.4) 7.3 (6.6-7.9) 0.64
C-reactive protein (mg/dL) 0.44 (0.36-0.51) 1.08 (0.33-1.82) 0.09
Homocysteine (umol/L) 9.4 (9.1-9.8) 12.1 (9.8-14.5) 0.04
% Microalbuminuria 30.4 (22.8-38.1) 33.8 (22.7-45.0) 0.63
Comorbidity index 0.0003
% 0 Comorbidities 22.9 (13.3-32.6) 2.2 (0.0-5.5)
% 1+ Comorbidities 77.0 (67.3-86.6) 97.7 (94.4-100.0)
% With Peripheral neuropathy 26.0 (15.8-36.3) 15.3 (2.0-28.5) 0.16
% On Medications to treat diabetes, cholesterol, or hypertension 79.4 (73.5-85.2) 86.8 (74.3-99.4) 0.36
An adjusted Wald test was used to examine differences for continuous variables, and a design-based likelihood ratio test was used for categorical variables.
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adjustments along with duration of diabetes, the results
were similar (RR = 0.66; 95% CI: 0.44-0.99).Discussion
The present findings are the first to demonstrate an as-
sociation between accelerometer-assessed physical activ-
ity and ABI among a nationally representative sample of
U.S. adults with evidence of diabetes. These data showed
that, after adjustments, adults with diabetes and an ab-
normal ABI engaged in 23% less MVPA time than their
counterparts with a normal ABI. Consequently, adult di-
abetics with peripheral arterial disease may be at an in-
creased risk of various chronic diseases associated with
physical inactivity.
A limitation of the present study is the cross-sectional
study design, which precludes any ability to render caus-
ation. Diabetics with peripheral arterial disease were
clearly less active than their counterparts, which suggest
that this condition may limit exercise tolerance, possibly a
result of pain duration ambulation. However, it is also
plausible to suggest that more active diabetics were less
likely to develop peripheral arterial disease due to the
benefits of physical activity. The present study cannot
determine the direction of association between physical
activity and peripheral arterial disease, but to spawn the
development of future work on this topic, the narrative
that follows will discuss the possibility of physicalactivity reducing the risk of peripheral arterial disease
incidence.
Diabetes may increase an individual’s risk for develop-
ing peripheral arterial disease through a variety of under-
lying mechanisms, all of which are favorably associated
with physical activity behavior. Most patients with dia-
betes demonstrate abnormalities in endothelial function
and vascular regulation, which increases the local in-
flammatory state of the vascular wall [1]. Previous stud-
ies have demonstrated a favorable association between
physical activity and endothelial function [30], with this
association likely occurring through physical activity-
induced changes in methionine catabolism, vitamin B
availability, inhibition of platelet aggregation and coagu-
lation, and improvements in blood rheology [31-33].
C-reactive protein, a biomarker of inflammation, has
been established as a risk marker and may exacerbate
peripheral arterial disease [34], and C-reactive protein
levels tend to be elevated among those with diabetes
[35]. Previous studies have demonstrated an inverse as-
sociation between physical activity and C-reactive protein
[36], with the underlying mechanism likely occurring
through changes in adiposity, which would help decrease
cytokine production (e.g., IL-1, TNF-alpha), along with
improvements insulin resistance and endothelial function
[5]. Indeed, in the present study, accelerometer-assessed
physical activity was inversely associated with C-reactive
protein (Table 2). Our findings also demonstrate an asso-
ciation between C-reactive protein and ABI (noted in the
Table 2 Negative binomial regression results examining the association between physical activity and ankle brachial
index, NHANES 2003-2004
Rate ratio (95% CI)
Variables Model 1 minimally adjusted Model 2 fully adjusted
Ankle brachial index
Normal (1–1.4) Referent Referent
Abnormal (<1 or >1.4) 0.69 (0.53-0.89) 0.77 (0.62-0.96)
Covariates
Age, 1 year older 0.95 (0.94-0.96) 0.95 (0.93-0.98)
Gender
Male Referent Referent
Female 0.61 (0.44-0.85) 0.66 (0.45-0.96)
Body mass index, 1 kg/m2 higher 0.95 (0.93-0.97) 0.96 (0.95-0.97)
Race-ethnicity
Non-hispanic white Referent Referent
Other 1.33 (0.96-1.83) 1.41 (1.08-1.85)
Comorbidity index
0 Comorbidities Referent Referent
1+ Comorbidities 1.13 (0.77-1.65) 1.27 (0.90-1.79)
Cotinine, 1 ng/mL higher N/A 1.00 (0.99-1.01)
HgbA1C, 1% higher N/A 0.99 (0.90-1.09)
C-reactive protein, 1 mg/dL higher N/A 0.88 (0.84-0.93)
Glomerular filtration rate, 1 unit higher N/A 0.99 (0.98-1.01)
Homocysteine, 1 umol/L higher N/A 0.98 (0.94-1.03)
Microalbuminuria
No Referent Referent
Yes N/A 0.97 (0.77-1.23)
Physical functioning
No functioning limitations Referent Referent
Some functioning limitations N/A 0.69 (0.51-0.94)
Peripheral neuropathy
No peripheral neuropathy Referent Referent
Having peripheral neuropathy N/A 1.13 (0.60-2.11)
Medications
Yes N/A 0.92 (0.60-1.43)
No Referent Referent
Model 1 (minimally adjusted) controlled for age, gender, body mass index, race-ethnicity, and comorbidity index.
Mode l 2 (fully adjusted) controlled for age, gender, body mass index, race-ethnicity, comorbidity index, cotinine, HgbA1C, C-reactive protein, glomerular filtration
rate, homocysteine, microalbuminuria, physical functioning, peripheral neuropathy, and medication use.
N/A = Not applicable; not entered into model.
Bold indicates statistical significance (p < 0.05).
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changes in C-reactive protein may, in part, help to explain
the association between physical activity and ABI.
In addition to their being biological plausibility to ex-
plain the association between physical activity and periph-
eral arterial disease, clinical exercise trials demonstrate
that exercise therapy among patients with peripheral ar-
terial disease may improve walking tolerance, walkingperformance, walking economy, modulate inflammatory/
hemostatic markers, enhance vasoresponsiveness, and in-
duce lower-extremity adaptations (e.g., mitochondrial syn-
thesis, angiogenesis) that may increase oxygen delivery
and enhance metabolic responses [37,38]. Not only may
physical activity help to reduce the risk of developing per-
ipheral arterial disease, but these findings underscore the
importance of promoting physical activity to those with
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disease.
In conclusion, to our knowledge, no study has exam-
ined the association between objectively-measured phys-
ical activity and peripheral arterial disease in a national
sample of adults with diabetes. Our findings demon-
strate that adult diabetics with peripheral arterial disease
engage in less physical activity than their counterparts.
Strengths of this study include this novel examination
among this understudied population, using an objective-
measure of physical activity, and employing a national
sample of adults with diabetes. A limitation includes the
cross-sectional design; therefore, future prospective and/
or experimental work among diabetics with peripheral
arterial disease is needed, while ensuring the utilization
of an objective-measure of physical activity. Clinicians
are encouraged to promote safe forms of physical activ-
ity among diabetics with peripheral arterial disease as
these individuals may be at an increased risk of various
chronic diseases associated with physical inactivity.
Using prospective and/or experimental designs, it would
also be informative to see if regular physical activity may
help to prevent peripheral arterial disease and attenuate
the progression of the disease.
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